Thyroid Hormone Inactivation in Gastrointestinal Stromal Tumors
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The ALBIOS trial in 1,818 patients with sepsis or septic shock found no difference between albumin plus crystalloids and crystalloids alone in 28-day or 90-day mortality.
“The largest clinical trial in sepsis, the ALBIOS trial comparing a combination of albumin and crystalloids to crystalloids alone in 1818 patients with sepsis or septic shock did not demonstrate a difference in 28-day (RR 1.0; 95% CI 0.87–1.14) or 90-day mortality (RR 0.94; 95% CI 0.85–1.05) [339].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [339]
Evidence shows higher blood pressure at early and later time points, higher static filling pressures, and lower net fluid balance with albumin.
“The suggestion to consider albumin in patients who received large volumes of crystalloids is informed by evidence showing higher blood pressure at early and later time points [339], higher static filling pressures [340], and lower net fluid balance [339] with albumin.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [339]
Albumin is theoretically more likely to maintain oncotic pressure than crystalloids.
“Although albumin is theoretically more likely to maintain oncotic pressure than crystalloids [339]”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [339]
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Sorted by citations
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935 · see citing works
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082 · see citing works
Albumin in critically ill patients
Caironi, P., Länger, T., & Gattinoni, L. (2015) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000223 · Cited by 62 · see citing works
Development and validation of a risk prediction score for severe acute pancreatitis
Hong, W., Lillemoe, K. D., Pan, S., Zimmer, V., Kontopantelis, E., Stock, S., Zippi, M., Wang, C., & Zhou, M. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1903-6 · Cited by 56 · see citing works
Park, C. H. L., de Almeida, J. P., de Oliveira, G. Q., Rizk, S. I., Fukushima, J. T., Nakamura, R. E., Mourão, M. M., Galas, F. R. B. G., Abdala, E., Pinheiro Freire, M., et al. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003900 · Cited by 51 · see citing works
Staubli, S. M., Schäfer, J., Rosenthal, R., Zeindler, J., Oertli, D., & Nebiker, C. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-54910-8 · Cited by 40 · see citing works
Impact of a Sequential Intervention on Albumin Utilization in Critical Care*
Lyu, P. F., Hockenberry, J. M., Gaydos, L. M., Howard, D. H., Buchman, T. G., & Murphy, D. J. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001638 · Cited by 30 · see citing works
Gene expression profiling of sequential metastatic biopsies for biomarker discovery in breast cancer
Foukakis, T., Lövrot, J., Sandqvist, P., Xie, H., Lindström, L. S., Giorgetti, C., Jacobsson, H., Hedayati, E., & Bergh, J. C. S. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.03.011 · Cited by 17 · see citing works
“Preliminary data show that in addition to efficacy, also safety outcomes may be predicted using this approach (Foukakis et al., 2014).”
Self-citationCampi, I., Dell’Acqua, M., Stellaria Grassi, E., Cristina Vigone, M., & Persani, L. (2023) · European Thyroid Journal · doi:10.1530/etj-23-0012 · Cited by 13 · see citing works
Pentraxin-3, Troponin T, N-Terminal Pro-B-Type Natriuretic Peptide in Septic Patients
Vassalli, F., Masson, S., Meessen, J. M. T. A., Pasticci, I., Bonifazi, M., Vivona, L., Caironi, P., Busana, M., Giosa, L., Macrí, M. M., et al. (2020) · Shock · doi:10.1097/shk.0000000000001543 · Cited by 10 · see citing works
Proposed benefits of albumin from the ALBIOS trial: a dose of insane belief
Caironi, P., & Gattinoni, L. (2014) · Critical Care · doi:10.1186/s13054-014-0510-4 · Cited by 9 · see citing works
Yazdani, M., Retter, A., Maggs, T., Li, P., Robson, M. G., Reid, C., Holmes, P. A., Garood, T., & Robinson, S. E. (2017) · Transfusion Medicine · doi:10.1111/tme.12406 · Cited by 6 · see citing works
Kreislauftherapie bei Sepsis – wann, wie und wie viel?
Kochanek, M., Shimabukuro‐Vornhagen, A., Eichenauer, D. A., & Böll, B. (2020) · Der Internist · doi:10.1007/s00108-020-00861-6 · Cited by 1 · see citing works
Kreislauftherapie bei Sepsis – wann, wie und wie viel?
Kochanek, M., Shimabukuro‐Vornhagen, A., Eichenauer, D. A., & Böll, B. (2020) · Wiener klinisches Magazin · doi:10.1007/s00740-020-00376-8 · Cited by 1 · see citing works
Russell, J. A., & Walley, K. R. (2015) · F1000Research · doi:10.12688/f1000research.6565.1
ICU Care Following Damage Control Surgery
Lee, C. W., Efron, P. A., & Moore, F. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-52429-0_16
- Authors
- Boikos, S. A., Helman, L. J., & Stratakis, C. A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2014-07-03
- Volume
- 371
- Issue
- 1
- Pages
- 84-87
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2406148105
- Cited by
- 24
- References
- 0
- Citations by year
- 2026: 2 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 3 · 2020: 4 · 2019: 3 · 2017: 4 · 2016: 1 · 2015: 2 · 2014: 1
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal Tumor Research and Treatment
- Health Sciences › Medicine › Epidemiology › Neuroendocrine Tumor Research Advances
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Keywords
- thyroid hormone inactivation, gastrointestinal stromal tumor, tyrosine kinase inhibitors, drug resistance, tyrosine kinase inhibitor resistance
- MeSH terms
- Gastrointestinal Neoplasms, Humans, Hypothyroidism, Iodide Peroxidase, Male, Thyroid Hormones, Gastrointestinal Stromal Tumors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
